TrialNature medicine2025

Effects of tirzepatide on circulatory overload and end-organ damage in heart failure with preserved ejection fraction and obesity: a secondary analysis of the SUMMIT trial.

Barry A Borlaug et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.